Le Lézard
Classified in: Health, Business
Subjects: JVN, SCZ

Citikliniken: Cooperation With BraineHealth Flourishes as They Double the Efforts in Improving Healthcare


STOCKHOLM, Dec. 30, 2019 /PRNewswire/ -- Citikliniken announced today that the Swedish company BraineHealth, which has its eyes set on improving both global and local healthcare, will continue their cooperation and expand its use of the Citikliniken facilities. BraineHealth will be implementing its innovative eHealth solutions for primary care in the Citikliniken test facility while simultaneously enforcing their patient-centered solutions for elderly care in the Lugn&Ro Vård och Omsorg facility.

Both the cooperation with the Citikliniken healthcare provider and the Lugn&Ro Vård och Omsorg project are the embodiment of BraineHealth's effort to make healthcare more efficient and accessible. With convenience and accessibility in mind, these facilities will provide easy access to resources to those that need them the most.

BraineHealth launched both these projects to provide a more individualized healthcare. Although these efforts are currently local, the company also has a global vision and the aim to democratize healthcare everywhere, making it attainable for each member of every community.

"Implementing eHealth solutions is an uphill battle, but having two facilities that allow more hands-on approach to healthcare will certainly expedite it," says Isabella Svensson, vice president of BraineHealth. 

She stresses that the Citikliniken testing facility already proved to be the pivotal move on BraineHealth's part, as it allows the users more choice when it comes to testing and provides an excellent starting point for further healthcare. 

At the same time, a sustainable, efficient, and patient-oriented elderly care facility ensures coherent healthcare for the more vulnerable members of society. With these two facilities, BraineHealth will successfully cover the Swedish healthcare market, thus ensuring that every member of each community has accessible, affordable care. 

This announcement takes BraineHealth one step further to their ultimate goal, which is democratized healthcare on a global level. 

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

https://mb.cision.com/Public/18299/2999890/b8001f8be757e72d_org.jpg

Familjen angelica 2

 

CONTACT:

Roger Svensson
CEO, PhD
[email protected]

Isabella Svensson Rissanen
vice president
[email protected]

SOURCE Brainehealth AB


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: